Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a minor system revision and does not alter the study details or visible page content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations for Paraná, Rio Grande do Sul, and São Paulo were added. The dedicated Paraná Locations, Rio Grande do Sul Locations, and São Paulo Locations sections were removed, and the revision updated to v3.3.3.SummaryDifference0.4%

- Check53 days agoChange DetectedThe revision label in the footer changed from 'Revision: v3.2.0' to 'Revision: v3.3.2'.SummaryDifference0.1%

- Check60 days agoChange Detected- Removed the government funding status notice from the study page, which previously warned that information may not be up to date due to funding delays.SummaryDifference0.4%

- Check74 days agoChange DetectedThe changes appear limited to layout and formatting updates with no modifications to core study details such as purpose, endpoints, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check103 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.